Annual Accounts Receivable
$24.47 M
+$5.75 M+30.75%
31 December 2022
Summary:
Sorrento Therapeutics annual accounts receivable is currently $24.47 million, with the most recent change of +$5.75 million (+30.75%) on 31 December 2022. During the last 3 years, it has risen by +$5.75 million (+30.75%). SRNE annual accounts receivable is now at all-time high.SRNE Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$32.73 M
+$6.20 M+23.38%
30 June 2023
Summary:
Sorrento Therapeutics quarterly accounts receivable is currently $32.73 million, with the most recent change of +$6.20 million (+23.38%) on 30 June 2023. SRNE quarterly accounts receivable is now at all-time high.SRNE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRNE Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +30.8% | +74.9% |
| 5 y5 years | +69.3% | +126.4% |
SRNE Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +30.8% | at high | +74.9% |
| 5 y | 5 years | at high | +69.3% | at high | +226.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Sorrento Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $32.73 M(+23.4%) |
| Mar 2023 | - | $26.52 M(+8.4%) |
| Dec 2022 | $24.47 M(+30.7%) | $24.47 M(+1.2%) |
| Sept 2022 | - | $24.19 M(-2.1%) |
| June 2022 | - | $24.71 M(+0.2%) |
| Mar 2022 | - | $24.67 M(+31.8%) |
| Dec 2021 | $18.71 M(+20.7%) | $18.71 M(+13.7%) |
| Sept 2021 | - | $16.45 M(-26.7%) |
| June 2021 | - | $22.44 M(+37.6%) |
| Mar 2021 | - | $16.31 M(+5.2%) |
| Dec 2020 | $15.51 M(+7.3%) | $15.51 M(+5.0%) |
| Sept 2020 | - | $14.77 M(+7.0%) |
| June 2020 | - | $13.80 M(+37.7%) |
| Mar 2020 | - | $10.02 M(-30.7%) |
| Dec 2019 | $14.45 M(+277.1%) | $14.45 M(+25.0%) |
| Sept 2019 | - | $11.56 M(+18.1%) |
| June 2019 | - | $9.79 M(+32.1%) |
| Mar 2019 | - | $7.41 M(+93.3%) |
| Dec 2018 | $3.83 M(+73.4%) | $3.83 M(+68.3%) |
| Sept 2018 | - | $2.28 M(+3.4%) |
| June 2018 | - | $2.20 M(-43.7%) |
| Mar 2018 | - | $3.91 M(+76.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $2.21 M(+30.4%) | $2.21 M(+30.6%) |
| Sept 2017 | - | $1.69 M(-28.7%) |
| June 2017 | - | $2.38 M(+1.6%) |
| Mar 2017 | - | $2.34 M(+37.9%) |
| Dec 2016 | $1.70 M(+87.8%) | $1.70 M(+222.4%) |
| Sept 2016 | - | $526.00 K(-39.3%) |
| June 2016 | - | $867.00 K(-24.3%) |
| Mar 2016 | - | $1.15 M(+26.9%) |
| Dec 2015 | $903.00 K(+23.4%) | $903.00 K(+45.2%) |
| Sept 2015 | - | $622.00 K(-30.7%) |
| June 2015 | - | $898.00 K(+14.5%) |
| Mar 2015 | - | $784.00 K(+7.1%) |
| Dec 2014 | $732.00 K(+85.8%) | $732.00 K(-25.8%) |
| Sept 2014 | - | $986.00 K(+71.2%) |
| June 2014 | - | $576.00 K(-12.3%) |
| Mar 2014 | - | $657.00 K(+66.8%) |
| Dec 2013 | $394.00 K(+393.7%) | $394.00 K(+976.5%) |
| Sept 2013 | - | $36.60 K(-60.5%) |
| June 2013 | - | $92.70 K(-30.9%) |
| Mar 2013 | - | $134.10 K(+68.0%) |
| Dec 2012 | $79.80 K(+30.4%) | $79.80 K(+30.4%) |
| Dec 2011 | $61.20 K | $61.20 K |
FAQ
- What is Sorrento Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Sorrento Therapeutics?
What is Sorrento Therapeutics annual accounts receivable?
The current annual accounts receivable of SRNE is $24.47 M
What is the all time high annual accounts receivable for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual accounts receivable is $24.47 M
What is Sorrento Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of SRNE is $32.73 M
What is the all time high quarterly accounts receivable for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly accounts receivable is $32.73 M